Brewing & distillation as a fermentation platform

verified 18 Jun 2026 valid until
EC: EU Spirit Drinks Regulation (EC No 110/2008) fda efsa

01Overview and value chain

Markers: [EC: EU Spirit Drinks Regulation (EC No 110/2008) | OECD: Food Systems | Regulator: FDA (USA), EFSA (EU)]

Brewing and distillation are the world’s most mature, high-volume fermentation industries (the global beer market ≈800B USD; typical beer ABV 4–6%; fermentation in 5–10 days; ethanol yields >90% of theoretical). Today their infrastructure is being reimagined as a bioeconomy platform: giant fermentation tanks of 250–500 m³, tuned yeast platforms (S. cerevisiae, Pichia pastoris) and distillation become CDMO capacity for recombinant proteins (collagen, egg albumin, dairy proteins) and biochemicals. AB InBev, through its BioBrew unit, already runs its plants as contract platforms for high-tonnage protein production. The synergy is ready infrastructure (bioreactors, purification, logistics) repurposed from alcohol to bio-ingredients.

Key directions of the fermentation platform:

  1. Recombinant-protein CDMO (Recombinant-Protein CDMO): 250–500 m³ tanks for collagen/albumin (BioBrew, Geltor).
  2. Biomass distillation (Biomass Distillation): ethanol as a platform node for biofuel and chemistry.
  3. Yeast platforms (Yeast Platforms): Pichia and S. cerevisiae for proteins and flavors.
  4. Beer & spirits (Beer & Spirits): the base market funding the retrofit.

Sectoral value chain

Value chain levels

LevelDescriptionKey inputs/outputs
Substrate Prepgrain mashing / sugar-wort preparationIn: grain/sugar, water. Out: wort.
Fermentation (Tanks)fermentation in 250–500 m³ tanksIn: wort, yeast. Out: fermented broth.
Yeast/Protein Recoveryyeast / target-protein separationIn: broth. Out: yeast/protein.
Distillation (Spirits)rectification column for ethanolIn: fermented broth. Out: ethanol.
Downstream (Protein)recombinant-protein purification for foodIn: broth. Out: pure protein.
Packaging (Fill)beer/spirits filling or protein dryingIn: product. Out: goods.

Cross-cutting technologies of the sector:

  • Industrial yeast platforms (Industrial Yeast Platforms): Pichia pastoris and S. cerevisiae for protein secretion.
  • Large-volume tanks (Large-Volume Tanks): 250–500 m³ — re-used as CDMO capacity.
  • Distillation (Distillation): rectification for ethanol and biochemical intermediates.

02US

The US repurposes brewing capacity into biotech via venture alliances and CDMO.

AB InBev BioBrew, Geltor/Every partnerships, FDA GRAS

  • AB InBev (BioBrew): plants as CDMO for recombinant proteins (Geltor, Every); FDA GRAS, FSSC 22000.
  • Capacity retrofit: brewing tanks for Pichia-secreted collagen and albumin.
  • FDA: GRAS routes for fermentation proteins.

03CN

China is the largest beer market and a growing spirits producer, localising yeast platforms.

Tsingtao, spirits scale, yeast localisation

  • Tsingtao: high-volume brewing and capacity modernisation.
  • Spirits industry: ethanol as a feedstock for chemistry and fuel.
  • Strain localisation: domestic yeast platforms for proteins and flavors.

04EU

The EU is the historic heart of brewing and distillation with strong regulation (Geographical Indications).

Heineken/Carlsberg/Diageo, EU GI regulation, EFSA

  • Heineken/Carlsberg: global brewing platforms with biotech expertise.
  • Diageo: distillation leader (whisky, gin) with a distillation platform.
  • EU (EC 110/2008 + EFSA): protection of geographical indications and safety of spirits/proteins.

05Leading companies and research institutes

Company / InstituteCountryKey products / platformsTech featuresStatus 2026
AB InBev🇧🇪 Belgiumbeer, BioBrew CDMO250–500 m³ tanks, PichiaCommercial
Heineken🇳🇱 Netherlandsglobal brewing platformscaled yeast platformsCommercial
Diageo🇬🇧 United Kingdomdistillation (whisky, gin)rectification columnsCommercial
Carlsberg🇩🇰 Denmarkbeer, research yeastyeast-science heritageCommercial
Molson Coors🇺🇸 USAbeer, fermentation capacityhigh-volume fermentationCommercial
Tsingtao🇨🇳 Chinabeer, capacity modernisationscale and localisationCommercial

06Tech stack and innovations

The stack rests on yeast platforms, large-volume tanks and distillation.

  1. Yeast platforms (Yeast Platforms):
    • Pichia pastoris and S. cerevisiae for recombinant-protein secretion; AB InBev/Geltor — collagen.
  2. Large-volume tanks (Large-Volume Tanks):
    • 250–500 m³ re-used as CDMO capacity for proteins.
  3. Distillation (Distillation):
    • ethanol rectification as a platform intermediate for biofuel and chemistry.

07Value chains and production pipelines

Fermentation-platform pipeline (FSSC 22000 / GMP)

Stage 1: Wort preparation

Grain is mashed (or sugar wort prepared) as the fermentation substrate.

Stage 2: Fermentation

Yeast (S. cerevisiae or Pichia) ferments the wort in 250–500 m³ tanks.

Stage 3: Recovery

Yeast and/or the target recombinant protein are separated from the broth by centrifugation.

Stage 4: Distillation / protein purification

For spirits — a rectification column; for protein — chromatographic purification.

Stage 5: Drying/formulation

The protein is spray-dried; spirits are brought to commercial strength.

Stage 6: Fill & serialisation

Beer/spirits are filled or the protein is packed; the batch goes to QC.

SupplierPriceLead timeCertificatesRiskConfidence
Heineken€1.5M14 wkISO 9001 FSSC 22000LowMEDIUM
Diageo£1.2M18 wkISO 9001LowMEDIUM
CarlsbergDKK 9M14 wkISO 9001 FSSC 22000LowMEDIUM
Molson Coors$1.1M16 wkISO 9001MediumMEDIUM
Tsingtao¥8M10 wkISO 9001 FSSC 22000LowMEDIUM
AI Recommendation AB InBev and Carlsberg offer the deepest fermentation R&D partnership infrastructure via their biotech venture arms. Tsingtao is the preferred CN-market co-production partner. Diageo leads for distillation-adjacent fermentation IP; Molson Coors is lowest priority for precision fermentation platform access.
Compliance Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.